Guidant (GDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sam Armstrong who wrote (20)	9/28/1997 4:33:00 PM
From: JMS	of 235

Sam, Guidant is in one of the few industries where the end user does not have the luxury of bargain-shopping. Margins therefore will stay at current level. Here's why you should buy long shares and some Apr. calls-GDT will be introducing new products over the next few months that will increase revenues by a substantial amount. With lack of margin pressure, earnings could go crazy a couple of quarters down the road. I would not be at all surprised to see the stock in the 90-100 range after the fda review in January and 2 more earnings reports. With the movement in the price recently, I'd look for either a 5 point run-up or a 5 point loss this week.(8-10% either way)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next